Advocacy intelligence hub — real-time data for patient organizations
International Extranodal Lymphoma Study Group (IELSG)
Henan Cancer Hospital
Gottfried von Keudell, MD PhD — PHASE2
Institute of Hematology & Blood Diseases Hospital, China — PHASE2
The First Affiliated Hospital of Soochow University — PHASE2
International Extranodal Lymphoma Study Group (IELSG)
Izidore Lossos, MD — PHASE2
Cancer Institute and Hospital, Chinese Academy of Medical Sciences — PHASE2
Second Affiliated Hospital, School of Medicine, Zhejiang University — PHASE2
National Taiwan University Hospital — PHASE2
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Markus Raderer, Prof
Department of Internal Medicine I
David Maloney
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
Shuhua Yi, Dr
Institute of Hematology & Blood Diseases Hospital, Chinese
Jun Shi
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Paolo Caimi, MD, M.D
Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center
📍 CLEVELAND, OH
Thomas G. Martin, MD
University of California, San Francisco